2.68
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Microbot Medical Inc Borsa (MBOT) Ultime notizie
Microbot Medical (NASDAQ:MBOT) Share Price Passes Above 200-Day Moving Average – Time to Sell? - Defense World
Microbot Medical Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Microbot Medical (MBOT) Projected to Post Earnings on Wednesday - Defense World
Renaissance Technologies LLC Takes $118,000 Position in Microbot Medical Inc. (NASDAQ:MBOT) - Defense World
Head to Head Survey: Microbot Medical (NASDAQ:MBOT) versus Hypertension Diagnostics (OTCMKTS:HDII) - Defense World
Geode Capital Management LLC Grows Stock Holdings in Microbot Medical Inc. (NASDAQ:MBOT) - Defense World
Cytosorbents (NASDAQ:CTSO) versus Microbot Medical (NASDAQ:MBOT) Financial Analysis - Defense World
Microbot Medical Releases Updated Presentation Materials - TipRanks
Microbot Medical regains Nasdaq compliance with bid price - MSN
Microbot Medical bolsters leadership ahead of FDA decision By Investing.com - Investing.com South Africa
Microbot Medical® Bolsters Commercial Leadership Team with the A - GuruFocus
Microbot Medical (MBOT) Strengthens U.S. Leadership Ahead of FDA Decision | MBOT Stock News - GuruFocus
Microbot Medical Strengthens Leadership Ahead of LIBERTY Launch - TipRanks
Microbot Medical bolsters leadership ahead of FDA decision - Investing.com
Microbot Medical® Bolsters Commercial Leadership Team with the Addition of Experienced Healthcare Officers | MBOT Stock News - GuruFocus
Microbot Medical® Bolsters Commercial Leadership Team with the Addition of Experienced Healthcare Officers - GlobeNewswire
Microbot Medical Accelerates FDA Launch Plans: Marketing VP with 15-Year Track Record Leads Commercial Push - Stock Titan
Is Microbot Medical Inc. (MBOT) the Best Rising Penny Stock to Buy According to Analysts? - Insider Monkey
10 Best Rising Penny Stocks to Buy According to Analysts - Insider Monkey
Microbot Medical announces proxy statement for annual meeting By Investing.com - Investing.com South Africa
Microbot Medical announces proxy statement for annual meeting - Investing.com
Microbot Medical modifies shareholder meeting quorum By Investing.com - Investing.com Canada
Microbot’s Liberty Boosts Stock: What’s Next? - timothysykes.com
Microbot Medical modifies shareholder meeting quorum - Investing.com
Global Robotic Exoskeleton Market Size Expected to Reach $30 Billion By 2032 as A.I. Influence Disrupts the Industry - GlobeNewswire
HC Wainwright Raises Earnings Estimates for Microbot Medical - Defense World
Microbot Medical's (MBOT) Robotic System Achieves Key Trial Succ - GuruFocus
HC Wainwright Reiterates Buy Rating for Microbot Medical (NASDAQ:MBOT) - Defense World
Microbot Medical clears pivotal study for remote-controlled endovascular procedures - Fierce Biotech
H.C. Wainwright maintains $9 target on Microbot Medical stock By Investing.com - Investing.com South Africa
Microbot Medical (MBOT) Awaits FDA Decision on LIBERTY® Robot - GuruFocus
Microbot posts pivotal surgical robot data; GE Healthcare hires Patient Care Solutions leader - Yahoo Finance
H.C. Wainwright maintains $9 target on Microbot Medical stock - Investing.com
Microbot Medical reports successful robotic trial By Investing.com - Investing.com Canada
Microbot Medical® Shares Results from Its Pivotal Clinical Trial - GuruFocus
Microbot Medical Data Backs Liberty Endovascular Surgical Robot - Medical Product Outsourcing
Sector Update: Health Care Stocks Rise Wednesday Afternoon - TradingView
Sector Update: Health Care - marketscreener.com
Microbot Medical (MBOT) Appoints Paul Mullen as VP of Sales - GuruFocus
Microbot Medical (MBOT) Advances Telesurgery with LIBERTY® Syste - GuruFocus
Microbot Medical (MBOT) Secures $13 Million Through Direct Offering - GuruFocus
Microbot Medical shares results from ACCESS-PVI pivotal trial - Vascular News
Microbot Medical Feels a Strong Surge Again? - timothysykes.com
Microbot Medical (MBOT) Unveils Promising Trial Data for LIBERTY System - GuruFocus
Microbot Medical (MBOT) Surges on Successful Trial Results - GuruFocus
Microbot Medical Shares Results from Its Pivotal Clinical Trial, Achieving 100% Robotic Navigation Success for the Liberty® Endovascular Robotic System - MarketScreener
Microbot Medical reports successful robotic trial - Investing.com
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):